2,670 results
Aegerion Pharmaceuticals, Inc. AEGR has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at AEGR given that, …
Stock-Callers.com has on its radar four these Biotech equities, namely: Merrimack Pharmaceuticals Inc. (NASDAQ: …
Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) announced, along with QLT Inc. (NASDAQ: QLTI), that the two companies have agreed to merge. Upon completion of the proposed merger, each outstanding share of Aegerion …
Trending on Bing
and VANCOUVER, B.C., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) …
Investors who purchased shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) prior to April 2013 and continue to …
Aegerion Pharmaceuticals Inc. (AEGR) announced after the close Tuesday that JUXTAPID has been approved by Japan's Ministry of Health, Labor & Welfare for the treatment of homozygous familial hypercholesterolemia. The stock is now up …
Aegerion Pharmaceuticals, Inc. AEGR announced that it has entered into a definitive ... Post completion, each outstanding share of Aegerion’s common stock will be exchanged for 1.0256 shares of QLT’s common stock. QLT will change its …
On Nasdaq, Aegerion Pharmaceuticals Inc (NASDAQ:AEGR) was setting the pace, up 44% at $1.92, as it agreed to be taken over by QLT Inc (NASDAQ:QLTI, TSE:QLT). Upon completion of the proposed merger, each outstanding share of …
and VANCOUVER, B.C., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) …